At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,016 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
XELJANZ(REGISTERED) TABLETS 5 MG SPECIAL INVESTIGATION(INVESTIGATION OF LONG-TERM USE IN PATIENTS WITH ULCERATIVE COLITIS)
In Brief
An observational study for Ulcerative Colitis. Completed, enrolled 2,016 participants across 1 site.
Detailed Summary
Secondary data collection study: safety and effectiveness of Xeljanz in UC patients under Japanese medical practice
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUlcerative Colitis
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedAug 2018
Primary CompletionNov 2022
TodayJul 2026
First PostedAug 22, 2018
Enrollment StartJun 8, 2018
Primary CompletionNov 10, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 7.9 years ago